| Kopran Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524280 |
NSE Symbol : KOPRAN |
P/E(TTM) : 30.22 |
|
ISIN Demat : INE082A01010 |
Div & Yield% : 1.58 |
EPS(TTM) : 6.30 |
|
Book Value(₹) : 92.75 |
Market Cap(₹Cr) : 919.36 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 118.04 | 93.88 | 42.39 | 51.33 | 75.94 | 71.94 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 118.04 | 93.88 | 42.39 | 51.33 | 75.94 | 71.94 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.00 | 0.32 | 0.32 | 1.80 | 1.92 | 0.75 |
| Total Income | 119.04 | 94.20 | 42.71 | 53.13 | 77.85 | 72.68 |
| Total Expenditure | 91.45 | 76.20 | 45.60 | 46.26 | 63.65 | 60.54 |
| PBIDT | 27.59 | 18.00 | -2.88 | 6.87 | 14.21 | 12.15 |
| Interest | 1.17 | 1.16 | 0.83 | 1.04 | 1.26 | 0.99 |
| PBDT | 26.42 | 16.84 | -3.71 | 5.83 | 12.95 | 11.16 |
| Depreciation | 1.34 | 1.25 | 1.16 | 1.22 | 1.24 | 1.33 |
| Tax | 5.78 | 3.25 | -1.08 | 1.08 | 2.74 | 2.37 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.55 | 0.20 | 0.20 | 0.01 | 0.37 | 0.05 |
| Reported Profit After Tax | 18.74 | 12.13 | -3.99 | 3.52 | 8.60 | 7.41 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 18.74 | 12.13 | -3.99 | 3.52 | 8.60 | 7.41 |
| EPS (Unit Curr.) | 3.88 | 2.51 | -0.83 | 0.73 | 1.78 | 1.54 |
| EPS (Adj) (Unit Curr.) | 3.88 | 2.51 | -0.83 | 0.73 | 1.78 | 1.54 |
| Calculated EPS (Unit Curr.) | 3.88 | 2.51 | -0.83 | 0.73 | 1.78 | 1.54 |
| Calculated EPS (Adj) (Unit Curr.) | 3.88 | 2.51 | -0.83 | 0.73 | 1.78 | 1.54 |
| Calculated EPS (Ann.) (Unit Curr.) | 15.53 | 10.05 | -3.31 | 2.91 | 7.13 | 6.15 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 15.53 | 10.05 | -3.31 | 2.91 | 7.13 | 6.15 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 48.29 | 48.29 | 48.29 | 48.29 | 48.21 | 48.21 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.37 | 19.17 | -6.79 | 13.38 | 18.71 | 16.89 |
| PBDTM(%) | 22.38 | 17.94 | -8.75 | 11.36 | 17.05 | 15.51 |
| PATM(%) | 15.88 | 12.92 | -9.41 | 6.86 | 11.32 | 10.30 |
